Can Parkinson’s Disease Cause Blurred Vision?
Blurred vision affects roughly one in four Parkinson’s patients, stemming from dopamine loss, medication effects, or overlapping eye conditions.
Blurred vision affects roughly one in four Parkinson’s patients, stemming from dopamine loss, medication effects, or overlapping eye conditions.
Smell loss in Parkinson’s disease affects up to 90% of patients, often years before motor symptoms appear.
Parkinson’s disease frequently causes or worsens chronic pain, with pain affecting up to 68% of patients and sometimes preceding movement symptoms.
Parkinson’s fatigue stems from dopamine loss, sleep disruption, medication timing, and inflammation—not laziness or mood.
Parkinson’s dopamine loss disrupts the brain circuits controlling foot muscles, causing painful toe curling and cramping—often worst when medication wears off.
As dopamine-producing brain cells die in Parkinson’s disease, the basal ganglia lose their ability to amplify motor commands, causing movements to shrink in size and distance.
Dyskinesia is an involuntary movement complication from long-term levodopa that affects 40% of Parkinson’s patients within five years.
Dyskinesia is involuntary movement caused by Parkinson’s medication—not the disease itself—and becomes more common as medication dosages increase over time.
Dystonia in Parkinson’s disease causes involuntary muscle contractions and abnormal postures—a sustained twisting movement distinct from tremor.
Parkinson’s causes stooped posture by damaging dopamine-producing neurons that normally control balance and keep the spine upright.